These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 2860120)

  • 1. Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.
    Moyse E; Le Dafniet M; Epelbaum J; Pagesy P; Peillon F; Kordon C; Enjalbert A
    J Clin Endocrinol Metab; 1985 Jul; 61(1):98-103. PubMed ID: 2860120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific somatostatin receptors on human pituitary adenoma cell membranes.
    Ikuyama S; Nawata H; Kato K; Karashima T; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1985 Oct; 61(4):666-71. PubMed ID: 2863281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions.
    Bertherat J; Brue T; Enjalbert A; Gunz G; Rasolonjanahary R; Warnet A; Jaquet P; Epelbaum J
    J Clin Endocrinol Metab; 1992 Aug; 75(2):540-6. PubMed ID: 1353505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.
    Ikuyama S; Nawata H; Kato K; Ibayashi H; Nakagaki H
    J Clin Endocrinol Metab; 1986 Apr; 62(4):729-33. PubMed ID: 2869049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of growth hormone-releasing hormone receptors in pituitary adenomas from patients with acromegaly.
    Ikuyama S; Natori S; Nawata H; Kato K; Ibayashi H; Kariya T; Sakai T; Rivier J; Vale W
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1265-71. PubMed ID: 2836473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density of somatostatin receptors in pituitary tumors from acromegalic patients.
    Reubi JC; Landolt AM
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1148-51. PubMed ID: 6092412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
    Ishibashi M; Yamaji T
    J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin and regulation of prolactin secretion.
    Enjalbert A; Bertrand P; Le Dafniet M; Epelbaum J; Hugues JN; Kordon C; Moyse E; Peillon F; Shu C
    Psychoneuroendocrinology; 1986; 11(2):155-65. PubMed ID: 2875480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential inhibition of growth hormone secretion by analogs selective for somatostatin receptor subtypes 2 and 5 in human growth-hormone-secreting adenoma cells in vitro.
    Tulipano G; Bonfanti C; Milani G; Billeci B; Bollati A; Cozzi R; Maira G; Murphy WA; Poiesi C; Turazzi S; Giustina A
    Neuroendocrinology; 2001 May; 73(5):344-51. PubMed ID: 11399907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.
    Reubi JC; Heitz PU; Landolt AM
    J Clin Endocrinol Metab; 1987 Jul; 65(1):65-73. PubMed ID: 3034958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas.
    Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F
    Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone (GH)-releasing hormone tonically inhibits in vitro endogenous somatostatin in human GH-secreting tumors.
    Mouhieddine OE; Levy L; Benlot C; Peillon F; Joubert D
    J Clin Endocrinol Metab; 1995 May; 80(5):1691-5. PubMed ID: 7745020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.
    Bertherat J; Chanson P; Dewailly D; Enjalbert A; Jaquet P; Kordon C; Peillon F; Timsit J; Epelbaum J
    Horm Res; 1992; 38(1-2):94-9. PubMed ID: 1306525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel somatostatin analog SOM230 is a potent inhibitor of hormone release by growth hormone- and prolactin-secreting pituitary adenomas in vitro.
    Hofland LJ; van der Hoek J; van Koetsveld PM; de Herder WW; Waaijers M; Sprij-Mooij D; Bruns C; Weckbecker G; Feelders R; van der Lely AJ; Beckers A; Lamberts SW
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1577-85. PubMed ID: 15070915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.
    Reubi JC; Landolt AM
    J Clin Endocrinol Metab; 1989 Apr; 68(4):844-50. PubMed ID: 2537844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas.
    Le Dafniet M; Brandi AM; Bression D; Racadot T; Peillon F
    J Clin Endocrinol Metab; 1983 Aug; 57(2):425-7. PubMed ID: 6306043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum prolactin and growth hormone response to thyrotropin-releasing hormone in patients with pituitary adenomas.
    Chang CC; Chen FW; Hsieh HC
    Taiwan Yi Xue Hui Za Zhi; 1989 May; 88(5):443-9. PubMed ID: 2507734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.